आईएसएसएन: 1745-7580
Ghazaleh Shoja E Razavi and Timothy Allen
Interleukins as a part of immune system were first represented in 1977. However, advancing knowledge of immune system and its role in pathogenesis of different diseases from allergic reactions to autoimmune disorders and even cancer makes these immune mediators an attractive target among different available treatment modalities. This article discusses the role of interleukins in cancer treatment.